bf/NASDAQ:PRQR_icon.png

COM:PROQR

ProQR Therapeutics

  • Stock

Last Close

3.61

22/11 21:00

Market Cap

295.62M

Beta: -

Volume Today

390.09K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
163.50K
-
437K
167.28%
858.50K
96.45%
621.50K
27.61%
486K
21.80%
449.50K
7.51%
3.43K
-
average payables
420K
-
996K
137.14%
1.07M
7.03%
606.50K
43.11%
437K
27.95%
340.50K
22.08%
290K
14.83%
333K
14.83%
206K
38.14%
291.50K
41.50%
967.13K
231.78%
average receivables
88.50K
-
278K
214.12%
691K
148.56%
675.50K
2.24%
395.50K
41.45%
819.50K
107.21%
1.05M
27.70%
635.50K
39.27%
488K
23.21%
28.90M
5,821.21%
29.25M
1.24%
book value per share
-0.00
-
9.87
246,479.11%
3.85
61.03%
2.28
40.84%
1.55
31.84%
2.73
75.89%
2.30
15.76%
1.14
50.39%
1.77
55.52%
0.91
48.45%
0.51
44.07%
capex per share
-0.01
-
-0.11
1,703.86%
-0.06
49.02%
-0.11
91.74%
-0.00
95.62%
-0.01
92.14%
-0.01
54.26%
-0.02
30.59%
-0.01
59.14%
-0.01
31.05%
-0.05
355.37%
capex to depreciation
-5.71
-
-9.79
71.43%
-2.76
71.81%
-2.04
26.07%
-0.11
94.43%
-0.31
176.83%
-0.28
10.13%
-0.39
38.81%
-0.21
47.03%
-0.28
35.14%
-1.48
427.38%
capex to operating cash flow
0.06
-
0.09
45.18%
0.05
35.94%
0.07
35.79%
0.00
95.33%
0.01
193.73%
0.01
29.72%
0.02
48.85%
0.02
5.23%
0.01
44.46%
-0.17
1,771.39%
capex to revenue
-3.94
-
-0.14
96.43%
-1.11
690.52%
0.08
107.11%
-0.06
179.79%
-0.30
375.18%
-0.36
-
-0.18
50.94%
-0.57
225.80%
cash per share
0.19
-
10.17
5,372.41%
4.06
60.05%
2.54
37.60%
1.90
25.25%
3.10
63.57%
2.73
12.01%
1.51
44.47%
2.92
92.86%
1.32
54.72%
1.47
11.06%
days of inventory on hand
days payables outstanding
1.39
-
days sales outstanding
496.77
-
37.09
92.53%
63.18
70.32%
-94.53
249.63%
91.82
197.13%
160.50
74.80%
149.61
-
5.17K
3,358.89%
72.60
98.60%
debt to assets
0.79
-
0.02
96.84%
0.05
94.58%
0.09
79.82%
0.14
56.94%
0.09
37.53%
0.12
35.39%
0.35
200.93%
0.29
17.03%
0.13
55.48%
0.04
66.60%
debt to equity
-39.78
-
0.03
100.07%
0.05
105.92%
0.11
98.96%
0.18
71.65%
0.10
45.07%
0.14
42.20%
0.60
317.66%
0.53
11.67%
0.34
36.75%
0.14
57.46%
dividend yield
earnings yield
-0.01
-
-0.06
345.36%
-0.11
83.57%
-0.36
223.54%
-0.63
73.25%
-0.08
87.45%
-0.16
98.86%
-0.27
72.62%
-0.14
49.64%
-0.26
92.37%
-0.19
27.39%
enterprise value
237.44M
-
89.37M
62.36%
96.43M
7.89%
54.67M
43.30%
28.82M
47.28%
373.19M
1,194.76%
264.66M
29.08%
131.21M
50.43%
326.80M
149.08%
175.46M
46.31%
45.84M
73.87%
enterprise value over ebitda
-74.41
-
-5.37
92.79%
-3.24
39.64%
-1.36
57.98%
-0.70
48.27%
-9.09
1,190.53%
-4.62
49.20%
-2.65
42.55%
-5.90
122.49%
-2.95
49.93%
-1.45
51.04%
ev to operating cash flow
-101.82
-
-6.18
93.93%
-3.98
35.63%
-1.60
59.85%
-0.82
48.38%
-12.16
1,374.90%
-6.02
50.51%
-2.79
53.68%
-12.56
350.62%
-2.56
79.61%
2.17
184.81%
ev to sales
285.54
-
10.25
96.41%
23.96
133.72%
-18.85
178.68%
75.53
500.66%
136.92
81.28%
241.36
-
43.46
81.99%
7.18
83.47%
free cash flow per share
-0.11
-
-1.42
1,173.69%
-1.09
22.67%
-1.57
43.82%
-1.38
12.22%
-0.91
34.15%
-1.09
19.27%
-0.96
11.71%
-0.41
56.93%
-0.97
134.03%
0.22
122.31%
free cash flow yield
-0.01
-
-0.08
659.18%
-0.14
74.06%
-0.34
147.93%
-0.50
48.12%
-0.07
86.88%
-0.12
85.84%
-0.28
126.34%
-0.06
78.98%
-0.28
377.67%
0.12
143.16%
graham net net
-0.02
-
9.69
58,821.07%
3.66
62.18%
2.04
44.28%
1.37
33.12%
2.63
92.27%
2.17
17.51%
0.68
68.67%
1.43
110.29%
0.44
69.19%
0.29
34.29%
graham number
0.11
-
15.59
13,468.03%
8.79
43.62%
9.26
5.38%
7.75
16.35%
8.16
5.27%
8.46
3.69%
4.89
42.20%
6.19
26.69%
4.32
30.30%
1.98
54.18%
income quality
0.72
-
1.19
66.30%
1.16
2.42%
0.87
24.80%
0.80
8.20%
0.83
3.03%
0.77
6.34%
1.01
30.29%
0.42
58.23%
1.06
150.34%
-0.77
172.59%
intangibles to total assets
0.01
-
0.00
83.67%
0.00
0.42%
0.00
2.51%
0.00
46.52%
0
100%
0
0
0
0
0
interest coverage
-85.24
-
-62.12
27.12%
-68.36
10.05%
-73.56
7.60%
-67.95
7.62%
-44.81
34.06%
-53.04
18.38%
-20.77
60.85%
-16.80
19.13%
-12.62
24.85%
-29.75
135.71%
interest debt per share
0.16
-
0.28
75.22%
0.22
20.56%
0.27
19.11%
0.31
15.69%
0.30
3.02%
0.36
19.09%
0.73
103.31%
0.99
36.97%
0.38
61.93%
0.09
76.96%
inventory turnover
invested capital
-39.78
-
0.03
100.07%
0.05
105.92%
0.11
98.96%
0.18
71.65%
0.10
45.07%
0.14
42.20%
0.60
317.66%
0.53
11.67%
0.34
36.75%
0.14
57.46%
market cap
238.03M
-
199.25M
16.29%
186.45M
6.42%
108.17M
41.98%
69.68M
35.59%
469.38M
573.65%
363.05M
22.65%
172.77M
52.41%
453.95M
162.76%
248.26M
45.31%
145.12M
41.55%
net current asset value
-332K
-
108.05M
32,646.39%
87.46M
19.06%
49.61M
43.28%
36.78M
25.86%
90.82M
146.92%
90.96M
0.16%
37.84M
58.40%
95.13M
151.42%
48.25M
49.28%
24.51M
49.20%
net debt to ebitda
0.18
-
6.60
3,475.53%
3.03
54.16%
1.33
55.96%
1.00
25.08%
2.34
134.68%
1.72
26.74%
0.84
51.05%
2.30
173.28%
1.23
46.61%
3.13
155.49%
net income per share
-0.15
-
-1.09
647.19%
-0.89
18.44%
-1.67
87.68%
-1.72
2.67%
-1.08
37.00%
-1.38
27.63%
-0.93
32.66%
-0.96
3.21%
-0.91
5.75%
-0.34
62.46%
operating cash flow per share
-0.10
-
-1.30
1,142.54%
-1.04
20.42%
-1.47
41.20%
-1.38
6.03%
-0.90
34.58%
-1.07
18.92%
-0.94
12.26%
-0.41
56.89%
-0.96
135.95%
0.26
127.25%
payables turnover
262.52
-
receivables turnover
0.73
-
9.84
1,239.24%
5.78
41.29%
-3.86
166.83%
3.98
202.95%
2.27
42.79%
2.44
-
0.07
97.11%
5.03
7,028.31%
research and ddevelopement to revenue
32.80
-
2.49
92.42%
13.99
462.35%
-20.37
245.65%
5.97
129.32%
24.05
302.65%
31.18
-
12.60
59.59%
3.55
71.79%
return on tangible assets
-0.73
-
-0.11
85.54%
-0.21
97.76%
-0.60
186.69%
-0.82
37.65%
-0.33
59.30%
-0.48
44.25%
-0.47
2.21%
-0.29
37.67%
-0.38
28.70%
-0.20
47.31%
revenue per share
0.03
-
0.40
1,326.90%
0.10
75.74%
-0.06
161.65%
0.15
340.80%
0.05
67.54%
0.02
-
0.06
167.11%
0.08
39.77%
roe
36.55
-
-0.11
100.30%
-0.23
109.29%
-0.74
217.22%
-1.11
50.64%
-0.40
64.18%
-0.60
51.50%
-0.82
35.72%
-0.54
33.64%
-0.99
82.85%
-0.66
32.89%
roic
-0.92
-
-0.09
89.80%
-0.20
113.18%
-0.66
230.99%
-0.87
30.76%
-0.35
59.18%
-0.53
49.73%
-0.39
26.17%
-0.30
23.30%
-0.63
109.86%
-0.56
11.80%
sales general and administrative to revenue
20.79
-
0.73
96.50%
4.15
471.46%
-7.09
270.69%
2.54
135.80%
6.67
162.69%
12.83
-
4.62
63.98%
2.54
44.92%
shareholders equity per share
-0.00
-
9.87
246,479.11%
3.85
61.03%
2.28
40.84%
1.55
31.84%
2.73
75.89%
2.30
15.76%
1.14
50.39%
1.77
55.52%
0.91
48.45%
0.51
44.07%
stock based compensation to revenue
2.06
-
0.13
93.76%
1.08
734.66%
-2.63
344.73%
0.65
124.79%
4.71
622.12%
4.59
-
0.71
84.52%
0.49
31.50%
tangible asset value
-128K
-
109.24M
85,444.53%
89.66M
17.93%
53.05M
40.84%
39.29M
25.94%
92.69M
135.92%
93.83M
1.24%
56.55M
39.74%
113.23M
100.24%
65.11M
42.49%
41.42M
36.38%
tangible book value per share
-0.01
-
9.86
171,155.24%
3.84
61.03%
2.27
40.84%
1.55
31.86%
2.72
75.80%
2.29
15.99%
1.13
50.60%
1.76
56.18%
0.91
48.48%
0.51
43.74%
working capital
659K
-
110.88M
16,725.95%
92.28M
16.77%
55.30M
40.07%
42.06M
23.94%
100.21M
138.22%
103.67M
3.46%
69.72M
32.75%
163.89M
135.06%
133.35M
18.63%
86.85M
34.87%

All numbers in (except ratios and percentages)